IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases

E-ISSN： 1873-4286|17|34|3776-3780

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.34, 2011-11, pp. : 3776-3780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases

By Leng Rui-Xue Pan Hai-Feng Tao Jin-Hui Ye Dong-Qing

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-21 with therapeutic potential in autoimmune diseases

By Xu Wang-Dong

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 659-665

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases

By Yan Jun-Wei Wang Yu-Jie Peng Wen-Jia Tao Jin-Hui Wan Ya-Nan Li Bao-Zhu Mei Bin Chen Bing Yao Hua Yang Guo-Jun Li Xiang-Pei Ye Dong-Qing Wang Jing

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Helminth Products as a Potential Therapeutic Strategy for Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. : 113-118

Bentham Science Publishers

Access to resources Recommend Favorite

The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite